Michael Mark
Impact in
-
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
- Diabetes Management and Research
- Surgery top 2%
- Pancreatic function and diabetes
Papers in
- Surgery 20
- Pancreatic function and diabetes 13
- Pancreatitis Pathology and Treatment 4
-
- Diabetes Treatment and Management 18
- Co-authors
- Eric Mayoux (6 shared papers)Ele Ferrannini (1 shared paper)Thomas Klein (17 shared papers)Leo Thomas (5 shared papers)Rolf Grempler (5 shared papers)Matthias Eckhardt (4 shared papers)Frank Himmelsbach (4 shared papers)Peter Eickelmann (4 shared papers)
- Journals
- Diabetes Obesity and Metabolism (4 papers)Scientific Reports (2 papers)Scandinavian Journal of Trauma Resuscitation and Emergency Medicine (2 papers)European Journal of Pharmacology (2 papers)Journal of Medicinal Chemistry (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Mark
46 papers receiving 3.1k citations
Michael Mark's Hit Papers
Peers
Comparison fields: 5 of 115
- Endocrinology, Diabetes and Metabolism 1.9k
- Surgery 890
- Nephrology 146
- Molecular Biology 934
- Cardiology and Cardiovascular Medicine 269
Countries citing papers authored by Michael Mark
This map shows the geographic impact of Michael Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mark more than expected).
Fields of papers citing papers by Michael Mark
This network shows the impact of papers produced by Michael Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mark. The network helps show where Michael Mark may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Mark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis Hit paper breakdown → | 2016 | 747 |
| 2 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 502 |
| 3 | SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition Hit paper breakdown → | 2020 | 281 |
| 4 | 2007 | 234 | |
| 5 | 2015 | 103 | |
| 6 | 2012 | 94 | |
| 7 | 2016 | 93 | |
| 8 | 2012 | 75 | |
| 9 | 1998 | 75 | |
| 10 | 2012 | 66 | |
| 11 | 2011 | 61 | |
| 12 | 2013 | 60 | |
| 13 | 2014 | 55 | |
| 14 | 2021 | 53 | |
| 15 | 2009 | 52 | |
| 16 | 2014 | 51 | |
| 17 | 1997 | 50 | |
| 18 | 2014 | 46 | |
| 19 | 2011 | 43 | |
| 20 | 2012 | 42 |
About Michael Mark
Michael Mark is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Molecular Biology, Emergency Medicine and Epidemiology, having authored 53 papers that have together received 3.2k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (18 papers), Pancreatic function and diabetes (13 papers), Metabolism, Diabetes, and Cancer (8 papers), Pancreatitis Pathology and Treatment (4 papers), Trauma and Emergency Care Studies (4 papers), Respiratory Support and Mechanisms (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Pharmacology and Obesity Treatment (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Surgery (890 citations), Nephrology (146 citations), Molecular Biology (934 citations) and Cardiology and Cardiovascular Medicine (269 citations). Michael Mark has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Eric Mayoux, Ele Ferrannini, Thomas Klein, Leo Thomas, Rolf Grempler, Matthias Eckhardt, Frank Himmelsbach, Peter Eickelmann, Achim Sauer and Dale E. Sharp. Their work appears in journals such as Diabetes Obesity and Metabolism, Scientific Reports, Scandinavian Journal of Trauma Resuscitation and Emergency Medicine, European Journal of Pharmacology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.